TOPIC

Biomedicine: Industry Trends

Related Topics:
Biomedicine: Companies
Biomedicine: Policy
Biomedicine: Science
Biomedicine: Industry Trends
Biomedicine: Geopolitics
Biomedicine: Industry Trends
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
Dalton Venture’s Hong Kong arm is expected to focus investments on life sciences and artificial intelligence. Photo: Shutterstock
Venture capital market

China life sciences-focused Dalton Venture expands operations to Hong Kong

The venture capital firm expects the size of its potential new fund in Hong Kong to range between US$103 million to US$129 million.

China property

Beijing, Shanghai lead global construction of life sciences centres, CBRE says

Biomedicine: Companies

Hutchmed weighs cancer drug’s supply-chain options amid trade war

videocam
Biomedicine: Companies

US report highlights China’s biotech rise, urges action to boost local industry

China is ‘quickly ascending to biotechnology dominance’ and the US must ‘take swift action in the next three years’, the report says.

4
The logo of Wuxi AppTec is displayed alongside the company’s website, in this illustration picture taken February 5, 2024. Photo: Reuters
Biomedicine: Companies

China’s biotech firms record surge in overseas licensing deals in first quarter

Chinese drug makers landed 33 licensing deals with overseas pharmaceutical firms, with transactions totalling US$36.2 billion.

Cancer

Groundbreaking cancer therapies are the goal for this biotech innovator

PostMag talks to 5 women innovators at the top of their game and pushing the boundaries of scientific discovery: here we meet Gina Jiang, managing director of the Hong Kong Institute of Biotechnology.

Advertisement
Advertisement
Advertisement
Biomedicine: Companies

Hong Kong biotech start-up Alephoson eyes global trial for eye-drug delivery

Hong Kong biotech start-up works with university partners to conduct global clinical trials studying prevalent eye diseases.

Benjamin Lee, a founder and CEO of Alephoson. Photo: Edmond So
New medical drugs

ClouDr shares rise on DeepSeek integration with medical AI platform

Chinese company says DeepSeek’s AI model will enhance data mining in its platform, delivering efficiency to hospitals and pharmacies.

videocam
Biomedicine: Companies

Chinese biotech firms cash in on promising drug discoveries via licensing

China has 4,804 new drug candidates under development, second only to the US at 5,268, according to data provider PharmCube.

videocam
Artificial intelligence

AI-driven drug discovery aided by Greater Bay Area integration, firm says

XtalPi says AI is reducing drug discovery times to two years from four.

videocam
XtalPi says AI could drastically cut the time for drug discovery, with regional integration across the Greater Bay Area also driving improvements. Photo: Handout
Artificial intelligence

China’s tech push: Shanghai aims to be global medical AI hub by 2027

Despite US export curbs on advanced chips, China’s financial powerhouse is betting big on medical AI.

Shanghai aims to transform itself into a global medical AI hub by 2027. Photo: Reuters
Science

China-born biologist Wang Cunyu returns from decades in US to head institute

Wang was recognised by Science magazine in 1996 for his work on cancer cell death.

videocam
43
New medical drugs

Novel drug awaits Hong Kong diabetics suffering from debilitating eye disease

Oculis’ OCS-01 eye drops, currently in phase 3 trials for diabetic macular edema, can be an alternative to injection, CEO says.

videocam
Biomedicine: Companies

China welcomes new US$1 billion Sanofi project in Beijing

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

Sanofi said the new plant in Beijing will be its fourth such facility on the mainland. Photo: Shutterstock
SCMP Highlights

Recap | ‘Promising’ steps to HIV vaccine, Trump tariffs threaten profits: 5 biotech stories

Discover breakthroughs in the biotech world, from a potential HIV cure to China’s booming drug market and innovative coronavirus treatments, in some of our latest stories.

A Hong Kong biotech start-up says its first-phase trial of a therapeutic HIV vaccine has shown promising results. Photo: dpa
Biomedicine: Companies

Chinese biotech firms brace for Trump tariffs, US funding bill

Efforts to expand sales of high-value products in China and non-US markets would cushion the blow, analysts say.

China economy

China No 2 in new drugs on the way as market scale tops US$13 billion

China has already approved nearly thrice the number of innovative drugs than in the 13th five-year plan, Shanghai forum hears.

videocam
10
Advertisement
Advertisement
Advertisement
Hong Kong

Vaccine shows promise in curing HIV, Hong Kong start-up says

‘We may be on the brink of a breakthrough,’ Dr Edward Leong, advisory board chairman of Immuno Cure says.

A Hong Kong biotech start-up says its first-phase trial of a therapeutic HIV vaccine has shown promising results. Photo: dpa
Health in China

Chinese pharmaceutical companies look abroad for growth markets

Shanghai Henlius struck a deal in Saudi Arabia while XtalPi signed a partnership with Sinar Mas Multiartha in Indonesia.

Greater Bay Area

Hong Kong health-tech start-ups create digital wearables for seniors

With a regulatory approach that expands the market for such devices to the Greater Bay Area, local companies see opportunity for growth.

videocam
Biomedicine: Companies

Hong Kong health tech: private-public alliance advances male HPV testing

Neo-Health Group says its device, developed with a government-backed research institute, will also help test for skin infections and cancers.

The Nanoswab device viewed through an optical microscope. Photo: Handout
Health & Fitness

Ultrasound cancer treatment, supported by Li Ka-shing, gains traction in Asia

Focused ultrasound, backed by Li Ka-shing, is emerging as a non-invasive, commercially viable cancer treatment, attracting significant investments.

videocam
Neal Kassell, a neurosurgeon, is the founder and chairman of US-based Focused Ultrasound Foundation. Photo: Sun Yeung
Science

China’s strides in academic research seen to narrow US lead in medical science

Growing momentum in research sets China up as a formidable player in future of global healthcare, according to scientific publishers.

videocam
39
China technology

China eyes sci-tech venture capital to boost industrial upgrade, economic growth

Premier Li Qiang said on Wednesday the development of venture capital is critical to sci-tech innovation, industrial upgrading and the growth of the economy.

China's economic recovery

Will medical tourists be the next to benefit from China’s visa-free push?

China is not generally considered a go-to option for healthcare and treatments, with the US, South Korea, Japan and Turkey already on the map.

videocam
8
Illustration: Brian Wang
Health & Fitness

Li Ka-shing’s HutchMed sets up first drugs research facility in Hong Kong

Research facility at the Hong Kong Science and Technology Park will conduct drug discovery in collaboration with university medical schools.

A view of Hong Kong Science and Technology Park in Pak Shek Kok. Photo: Winson Wong
Banking & finance

Hong Kong attracts US$832 million in investment from life-science firms

The investments, which will yield 3,200 jobs, come amid government efforts to enhance Hong Kong’s position as an innovation hub in the field.

Banking & finance

Shanghai’s US$13.8 billion fund of funds to boost AI, semiconductor firms

Mainland China’s commercial and financial hub plans to set up a 100 billion yuan (US$13.8 billion) fund of funds focusing on key technology sectors to fire up the local economy.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement